Interleukin-10
EmergingCSF IL-10, especially the IL-10:IL-6 ratio, is a supportive marker helping diagnose primary CNS lymphoma before biopsy.
IL-10 usually calms down inflammation, but in spinal fluid, unusually high levels are actually a clue pointing toward a specific type of brain lymphoma, helping doctors distinguish it from other possible causes of a brain lesion before doing a biopsy.
Interleukin-10 (IL-10) is an anti-inflammatory cytokine that, somewhat counterintuitively, is often elevated in certain aggressive disease states rather than only in states of immune suppression.
Markedly high cerebrospinal fluid (CSF) IL-10, especially an elevated IL-10:IL-6 ratio, is a well-established supportive marker for primary CNS lymphoma, helping distinguish it from other CNS lesions (like inflammatory demyelinating disease or other tumors) before biopsy confirmation.
Measured via CSF immunoassay in the specific context of suspected primary CNS lymphoma workup, alongside imaging and eventual tissue biopsy for definitive diagnosis; it's a supportive, not standalone diagnostic, test.
An elevated CSF IL-10:IL-6 ratio supports proceeding with a diagnostic biopsy for suspected primary CNS lymphoma with greater confidence, though biopsy remains the definitive diagnostic step in essentially all cases.
An example of an anti-inflammatory cytokine paradoxically serving as a marker of aggressive malignant disease.
- General neuro-oncology reference literature on CSF IL-10 and the IL-10:IL-6 ratio in primary CNS lymphoma diagnosis.